ELOVL1-IN-2(Cat No.:I044018)is a small molecule inhibitor designed to target ELOVL1 (elongation of very long chain fatty acids protein 1), an enzyme involved in the synthesis of long-chain fatty acids. By inhibiting ELOVL1, this compound can potentially regulate lipid metabolism, which plays a crucial role in various cellular functions, including membrane structure and energy storage. ELOVL1-IN-2 is being explored for its therapeutic potential in metabolic disorders, skin conditions, and diseases linked to lipid imbalances. Its ability to modulate lipid synthesis offers new opportunities for treatment development in related diseases.